Moving Beyond Fixed Dosing: Using Quantitative Dosimetry to Deliver Truly Personalised TRP Treatment

2:00 pm - Wednesday 2nd December 2026

  • Addressing significant interpatient variability in tumour uptake, organ exposure and clearance that limits the effectiveness of one-size-fits-all dosing strategies
  • Leveraging patient-specific dosimetry to optimise administered activity, retreatment schedules and cumulative dose exposure across different tumour and isotope settings
  • Understanding how personalised dosimetry may improve efficacy, reduce unnecessary toxicity and support broader adoption of precision radioligand therapy approaches

Speakers:

Chief Executive Officer
Blue Earth Therapeutics Ltd.